| |

Recent developments in gene transfer research: risk and ethics

Recent developments in gene transfer research: risk and ethics Mon, 10 Jan 2005 An analysis by Dr. Jonathan Kimmelman, in the British Medical Journal provides an illuminating, clearly articulated discussion about the ethical dilemmas that challenge gene transfer experiments – essentially a kind of human genetic engineering involving somatic cells,…

Public Servant or Private Marketer? NIH Seeks Inquiry of Alzheimer’s researcher conflicts of interest

NIH: Public Servant or Private Marketer? NIH Seeks Outside Inquiry of Alzheimer’s researcher conflicts of interest – LAT Mon, 31 Jan 2005 A year after the Los Angeles Times published its first an in-depth investigative report documenting in detail evidence of major conflicts of interest by top scientists at the…

Alabama Filed Suit against 79 Drug companies Medicaid Overcharges

Alabama Filed Suit against 79 Drug companies Medicaid Overcharges Sat, 29 Jan 2005 The prescription drug industry is continuing to fleece the American taxpayer – Alabama filed a lawsuit charging 79 drug companies – among them the giants, Eli Lilly, Pfizer, Brsitol-Myers, and Merck – for "intentionally" misreporting and inflating…

Lilly Withdraws Duloxetine Application from FDA

Lilly Withdraws Duloxetine Application from FDA Fri, 28 Jan 2005 Eli Lilly and Boeringer Ingelheim have jointly announced that they have recinded their U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence. http://newsroom.lilly.com/ReleaseDetail.cfm?ReleaseID=154081&print=yes Withdrawal of an application from FDA approval process is usually the result of the manufacturer’s…

Pittman-Zoloft Trial to begin_ Another Boy on Prozac is Charged in Father’s Slaying – AP

Pittman-Zoloft Trial to begin_ Another Boy on Prozac is Charged in Father’s Slaying – AP Sun, 30 Jan 2005 The Associated Press reports about a homicide case (below) – this time involving a 10 year old boy who is charged with killing his father. AP reports that the child was…

FATAL FLAW Efforts to Overturn SSRI Black Box warning before it has even been implemented

FATAL FLAW Efforts to Overturn SSRI Black Box warning before it has even been implemented Date: Mon, 24 Jan 2005 Even as the Black Box Suicidality Warning on SSRI antidepressant labels have not even been implemented, aggressive efforts are underway by a powerful consortium of medical-pharmaceuticaql self-interest groups – among…

DHHS Report: Contradicting itself on drug imports – OpEd Peter Rost

DHHS Report: Contradicting itself on drug imports – OpEd Peter Rost Wed, 5 Jan 2005 Dr. Peter Rost, a Pfizer Vice-President of Marketing knows about the financial underpinnings of drug pricing. He has taken a consciencious public position (unsusual in that industry) because he believes the American public has a…

Intimidation, Politics and Drug Industry Cripple U.S. Medicine – FDA Permits Dr. David Graham to publish Vioxx Report

Intimidation, Politics and Drug Industry Cripple U.S. Medicine – FDA Permits Dr. David Graham to publish Vioxx Report Wed, 5 Jan 2005 FDA officials could not maintain their iron grip in an effort to suppress evidence of far reaching lethal effects of Vioxx when their actions were in full public…

Lies & Broken Promises – Drug firm Websites Fail to Disclose Test Data

Lies & Broken Promises_Drug firm Websites Fail to Disclose Test Data Sun, 9 Jan 2005 One year after PhRMA’s publicized proclamation of its “commitment to transparency” The Boston Globe reviewed pharmaceutical company websites searching for disclosure of clinical trial data. The Globe found that this voluntary approach failed miserably: “Last…

Corporate Culture of Denial Results in Preventable Deaths

Corporate Culture of Denial Results in Preventable Deaths Fri, 7 Jan 2005 Failure to disclose the hazardous effects of Vioxx and Prozac are evidence of a corporate culture that has run amok. Uncovered company documents – some obtained through litigation, others unearthed by whistleblowers – reveal that the manufacturers knew…